All the Active Ingredient Drugs
Anti Cholinergic, β2 Receptor Agonist. Umeclidinium 55 mcg, Vilanterol 22 mcg. INH. (pwdr. for inh.): 7, 30. One inh. once
dly., at the same time of the day ea.
day, to maint. bronchodil. The max.
dose is one inh. once dly.
Maint. bronchodil. tmt. to relieve sympt. in
adult pts. with COPD.
This drug is NOT indic. for the relief of
acute bronchospasm or for the tmt. of
Corticosteroid, β2 Adrenergic Agonist. Vilanterol 22 mcg, Fluticasone 92, 184 mcg. PRE-DISPENSED INHAL. PWDR. (with inhal. device): 14, 30. Asthma- Adult., adolesc. >12 yrs.: 1 inhal. of 92/22 mcg ×1/d or 1 inhal. of 184/22 mcg×1/d. Init. dose of 92/22 mcg should be consid. for adult., adolesc. 12 yrs. and over who require a low to mid dose of inhal. corticost.in comb.with a long act. β-2-ag. If pts. are inadeq. control. On 92/22 mcg , the dose can be incr. to 184/22 mcg. Max. recom. dose is 184/22 mcg ×1/d. COPD Adult.>18 yrs.: 1 inhal. of 92/22 mcg ×1/d. See lit.
92/22 mcg, 184/22 mcg indic. for the regular tmt. of asthma in adul. and adolescen. 12 yrs. and old.where use of a comb. med. product (long-act. β-2- ag. ,inhal. corticoster.) is appropr.: Pts. notadequat. control. with inhal. corticoster. and ‘as needed’ inhal.shortact. β-2-ag. 92/22 mcg is indic. For the sympt. tmt. of adult. with COPD with a FEV1<70% predict. normal (postbronchodilator) with an exacerb. hist. despite regular bronchodilator ther.
Corticosteroid, LABA, Long-acting Muscarinic Receptor Antagonist. Fluticasone Furoate 92 mcg, Umeclidinium Bromide 65 mcg, Vilanterol (as trifenatate) 22 mcg. INHALAT. PWDR., PRE-DISPENS.: 1×14, 30 doses. Applied once dly. See lit.
Long-term, once-dly., maintenan. tmt. of airflow obstruct. in pts. with COPD, includ. chron. bronchit. and/or emphysema.
Indicated to reduce exacerbat. of COPD in pts. with a history of exacerbat.
Important Limitations of Use: NOT indicat. for the relief of acute bronchospasm or for the tmt. of asthma.